Name: Dr. Olha Kos
Lab Position: Research Technologist I
Degree: PhD
Education: PhD in pharmaceutical biology at Albert-Ludwig University Freiburg, (Germany)
What’s your research background?
In the past I studied the effects of CD200:CD200R1 interaction on osteoblasto- and osteoclastogenesis here on earth and in a space in a condition of weightlessness.
I measured changes in serum levels of soluble CD200 and CD200R1 and other markers of bone metabolism in the serum of the bed rest study participants
In a breast cancer model, I looked at miRNA profiles of the exosomes and analyzed genes involved in breast cancer metastasis.
Currently I’m evaluating the efficacy of checkpoint inhibitors combinations in MMRD brain tumor mouse models.